NASDAQ:BCAB

Bioatla Stock Insider Trading

etoro logo Buy BCAB
*Your capital is at risk
$3.40
-0.130 (-3.68%)
At Close: Jun 03, 2026

BioAtla Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.52. In total, the insiders bought 3.76M and sold 242.04K BCAB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
99.52
Buy 3.76M shares
Sell 242.04K shares
40% Buy Activity
Negligible or No Correlation
Buy Signal Medium Confidence
Mar 11, 2026

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 99.52.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Mar 11, 2026
Buy
Common Stock
A-Award
Short Jay M Phd
Chief Executive Officer
CEO / President 430 000
Value: $3.64M
Mar 10, 2026
Buy
Common Stock
A-Award
Sievers Eric
Chief Medical Officer
Officer 240 000
Value: $2.07M
Mar 10, 2026
Buy
Common Stock
A-Award
Vasquez Christian
Chief Financial Officer
C-Suite Officer 240 000
Value: $2.07M
Feb 28, 2026
Sell
Common Stock
F-InKind
Sievers Eric
Chief Medical Officer
Officer 3 140
Value: $776
Feb 28, 2026
Sell
Common Stock
F-InKind
Short Jay M Phd
Chief Executive Officer
CEO / President 7 728
Value: $2K
Feb 28, 2026
Sell
Common Stock
F-InKind
Vasquez Christian
Chief Financial Officer
C-Suite Officer 1 802
Value: $445
Feb 28, 2026
Sell
Common Stock
F-InKind
Waldron Richard A
Former Chief Financial Officer
C-Suite Officer 2 729
Value: $674
Nov 30, 2025
Sell
Common Stock
F-InKind
Short Jay M Phd
Chief Executive Officer
CEO / President 6 347
Value: $6K
Nov 30, 2025
Sell
Common Stock
F-InKind
Sievers Eric
Chief Medical Officer
Officer 2 729
Value: $2K
Nov 30, 2025
Sell
Common Stock
F-InKind
Waldron Richard A
Chief Financial Officer
C-Suite Officer 2 371
Value: $2K
Nov 30, 2025
Sell
Common Stock
F-InKind
Vasquez Christian
See Remarks
Officer 1 566
Value: $1K
Aug 31, 2025
Sell
Common Stock
F-InKind
Short Jay M Phd
Chief Executive Officer
CEO / President 6 347
Value: $3K
Aug 31, 2025
Sell
Common Stock
F-InKind
Vasquez Christian
See Remarks
Officer 1 566
Value: $713
Aug 31, 2025
Sell
Common Stock
F-InKind
Sievers Eric
Chief Medical Officer
Officer 2 729
Value: $1K
Aug 31, 2025
Sell
Common Stock
F-InKind
Waldron Richard A
Chief Financial Officer
C-Suite Officer 2 371
Value: $1K
Aug 31, 2025
Sell
Common Stock
F-InKind
Waldron Richard A
Chief Financial Officer
C-Suite Officer 2 371
Value: $1K
Aug 31, 2025
Sell
Common Stock
F-InKind
Sievers Eric
Chief Medical Officer
Officer 2 729
Value: $1K
Aug 31, 2025
Sell
Common Stock
F-InKind
Vasquez Christian
See Remarks
Officer 1 566
Value: $713
Aug 31, 2025
Sell
Common Stock
F-InKind
Short Jay M Phd
Chief Executive Officer
CEO / President 6 347
Value: $3K
Jun 18, 2025
Buy
Common Stock
A-Award
Moran Susan
Director
Director 23 500
Value: $468.2K
Jun 18, 2025
Buy
Common Stock
A-Award
Williams Eddie
Director
Director 23 500
Value: $468.2K
Jun 18, 2025
Buy
Common Stock
A-Award
Steinman Lawrence
Director
Director 23 500
Value: $468.2K
Jun 18, 2025
Buy
Common Stock
A-Award
Gray Mary Ann
Director
Director 23 500
Value: $468.2K
Jun 18, 2025
Buy
Common Stock
A-Award
Mcbrinn Sylvia
Director
Director 23 500
Value: $468.2K
Jun 18, 2025
Buy
Common Stock
A-Award
Smith Scott Andrew
Director
Director 23 500
Value: $468.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT BIOATLA, INC.
BioAtla
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, mel...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE